Page last updated: 2024-08-24

gemcitabine and Thrombotic Microangiopathies

gemcitabine has been researched along with Thrombotic Microangiopathies in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (4.17)	29.6817
2010's	15 (62.50)	24.3611
2020's	8 (33.33)	2.80

Authors

Authors	Studies
Kashima, H; Kimura, Y; Kusumi, F; Matsumoto, A; Minami, R; Ohana, M; Okano, A; Ozawa, T; Takeda, Y; Ueo, T	1
Horino, T; Inotani, S; Ishihara, M; Terada, Y	1
Allard, J; Bonnet, M; Bouattour, M; Gagaille, MP; Laurent, L; Leclerc, V	1
Esposito, F; Font, C; Garcia de Herreros, M; Sauri, T	1
Aklilu, AM; Shirali, AC	1
Akagi, N; Burns, ST; Damon, L; Ko, AH; Laszik, Z	1
Hara, S; Hiramoto, N; Ishikawa, T; Nishikubo, M; Sawamura, N; Shimomura, Y; Yamaguchi, T	1
Benhamou, Y; Chiche, NJ; Coindre, JP; Coppo, P; Daviet, F; François, A; Frémeaux-Bacchi, V; Grall, M; Grangé, S; Guerrot, D; Karras, A; Pouteil-Noble, C; Presne, C; Provot, F; Veyradier, A	1
Cassier, P; Charmetant, X; Fournier, T; Jolivot, A; Juillard, L; Lemoine, S; Puthet, JC	1
Bittar, PG; Nickolich, MS; Onwuemene, OA	1
Hinoshita, F; Katagiri, D	1
Burtey, S; Coppo, P; Daviet, F; Duffaud, F; Frémeaux-Bacchi, V; Grandvuillemin, A; Grange, S; Jourde-Chiche, N; Mancini, J; Micallef, J; Moussi-Francès, J; Poullin, P; Pourroy, B; Rouby, F; Sabatier, R; Sallée, M	1
Carvalheira, JB; Leal, F; Macedo, LT	1
Abro, E; Gilbar, P; Richmond, J	1
Aster, RH; Bougie, DW; Curtis, BR; George, JN; Reese, JA; Terrell, DR; Vesely, SK	1
Izzedine, H; Perazella, MA	1
Broussolle, C; Gerfaud-Valentin, M; Guillet, M; Noel, A; Pouteil-Noble, C; Rogier, T; Sève, P; Taleb, A	1
Atallah, JP; Garcia, G	1
Hagiwara, M; Hara, M; Hirayasu, K; Kojima, T; Nishiyama, H; Usui, J; Yamagata, K; Yokoyama, C; Yoshino, T	1
Nanjappa, S; Pabbathi, S; Singh, V; Uttamchandani, S	1
Liew, A; Magee, C; Phelan, PJ	1
Bult, P; van Herpen, CM; van Laarhoven, HW; Wesseling, P; Willemsen, AE	1
Norby, SM; Sethi, S; Thomas, JG	1
Cañueto, J; Fernández-López, E; Mir-Bonafé, JM; Román-Curto, C; Santos-Briz, A; Unamuno, P	1

Reviews

3 review(s) available for gemcitabine and Thrombotic Microangiopathies

Article	Year
Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature. Anticancer research, 2020, Volume: 40, Issue:7 Topics: Adult; Albumins; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Complement Inactivating Agents; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Male; Paclitaxel; Pancreatic Neoplasms; Thrombotic Microangiopathies	2020
Thrombotic microangiopathy, cancer, and cancer drugs. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 66, Issue:5 Topics: Adrenal Cortex Hormones; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Deoxycytidine; Gemcitabine; Humans; Immunosuppressive Agents; Kidney; Male; Neoplasms; Pancreatic Neoplasms; Plasmapheresis; Thrombotic Microangiopathies; Vascular Endothelial Growth Factor A	2015
Antineoplastic agents and thrombotic microangiopathy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2017, Volume: 23, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Immunologic Factors; Incidence; Interferon-alpha; Mitomycin; Molecular Targeted Therapy; Neoplasms; Proteasome Inhibitors; Signal Transduction; Thrombotic Microangiopathies; Vascular Endothelial Growth Factor A	2017

Other Studies

21 other study(ies) available for gemcitabine and Thrombotic Microangiopathies

Article	Year
[A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2022, Volume: 119, Issue:3 Topics: Deoxycytidine; Gemcitabine; Humans; Male; Pancreatic Neoplasms; Renal Dialysis; Thrombotic Microangiopathies	2022
Gemcitabine-induced renal thrombotic microangiopathy. Nephrology (Carlton, Vic.), 2022, Volume: 27, Issue:8 Topics: Deoxycytidine; Gemcitabine; Humans; Kidney; Thrombotic Microangiopathies	2022
Microangiopathy associated with gemcitabine: a drug interaction with nab-paclitaxel? A case series and literature review. European journal of clinical pharmacology, 2022, Volume: 78, Issue:7 Topics: Adenocarcinoma; Albumins; Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Interactions; Gemcitabine; Humans; Mice; Paclitaxel; Pancreatic Neoplasms; Thrombotic Microangiopathies	2022
Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Paclitaxel; Pancreatic Neoplasms; Purpura, Thrombotic Thrombocytopenic; Thrombotic Microangiopathies	2023
Chemotherapy-Associated Thrombotic Microangiopathy. Kidney360, 2023, 03-01, Volume: 4, Issue:3 Topics: Antineoplastic Agents; Gemcitabine; Humans; Neoplasms; Proteasome Inhibitors; Thrombotic Microangiopathies	2023
Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report. BMC nephrology, 2021, 05-12, Volume: 22, Issue:1 Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Humans; Kidney; Lymphoma, T-Cell; Middle Aged; Thrombotic Microangiopathies	2021
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre. BMC nephrology, 2021, 07-21, Volume: 22, Issue:1 Topics: Acute Kidney Injury; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Blood Transfusion; Complement Inactivating Agents; Deoxycytidine; Female; France; Gemcitabine; Humans; Kidney Function Tests; Male; Middle Aged; Recovery of Function; Remission Induction; Renal Replacement Therapy; Thrombotic Microangiopathies; Treatment Outcome	2021
[Gemcitabine-induced thrombotic microangiopathy: Can we improve screening and treatment?] Nephrologie & therapeutique, 2017, Volume: 13, Issue:4 Topics: Adult; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Plasma Exchange; Severity of Illness Index; Thrombotic Microangiopathies	2017
ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy. Journal of clinical apheresis, 2018, Volume: 33, Issue:3 Topics: ADAMTS13 Protein; Deoxycytidine; Diagnosis, Differential; Female; Gemcitabine; Humans; Middle Aged; Plasma Exchange; Practice Guidelines as Topic; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Thrombotic Microangiopathies	2018
Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome. CEN case reports, 2018, Volume: 7, Issue:2 Topics: Acute Kidney Injury; Aftercare; Antimetabolites, Antineoplastic; Conservative Treatment; Deoxycytidine; Female; Gemcitabine; Humans; Kidney; Middle Aged; Nephrotic Syndrome; Thrombotic Microangiopathies; Treatment Outcome	2018
Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort. British journal of clinical pharmacology, 2019, Volume: 85, Issue:2 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; France; Gemcitabine; Humans; Male; Middle Aged; Neoplasms; Pharmacovigilance; Retrospective Studies; Thrombotic Microangiopathies	2019
Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series. Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:3 Topics: Adult; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Humans; Incidence; Male; Middle Aged; Neoplasms; Retrospective Studies; Thrombotic Microangiopathies	2014
Gemcitabine-induced thrombotic microangiopathy. Internal medicine journal, 2013, Volume: 43, Issue:11 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Thrombotic Microangiopathies	2013
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. American journal of hematology, 2015, Volume: 90, Issue:5 Topics: Ambulatory Care Facilities; Antibodies; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Oklahoma; Organoplatinum Compounds; Oxaliplatin; Pentostatin; Purpura, Thrombotic Thrombocytopenic; Quinine; Registries; Thrombotic Microangiopathies; Vancomycin; Wisconsin	2015
[Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report]. La Revue de medecine interne, 2016, Volume: 37, Issue:10 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Deoxycytidine; Female; Gemcitabine; Humans; Pancreatic Neoplasms; Thrombotic Microangiopathies; Treatment Outcome	2016
The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients. Clinical laboratory, 2016, Dec-01, Volume: 62, Issue:12 Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms; Nephrotic Syndrome; Podocytes; Predictive Value of Tests; Protein Kinase Inhibitors; Retrospective Studies; Thrombotic Microangiopathies; Time Factors; Urinalysis; Urine	2016
Thrombotic Microangiopathy in a Patient Treated With Gemcitabine. Cancer control : journal of the Moffitt Cancer Center, 2017, Volume: 24, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Thrombotic Microangiopathies	2017
A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke. Renal failure, 2009, Volume: 31, Issue:8 Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Hypertension; Pancreatic Neoplasms; Stroke; Thrombotic Microangiopathies	2009
Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma. Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxycytidine; Dose-Response Relationship, Drug; Fatal Outcome; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Metastasis; Palliative Care; Salvage Therapy; Thrombotic Microangiopathies	2011
Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 57, Issue:5 Topics: Antimetabolites, Antineoplastic; Chronic Disease; Deoxycytidine; Gemcitabine; Granulomatosis with Polyangiitis; Humans; Male; Middle Aged; Thrombotic Microangiopathies; Urinary Bladder Neoplasms	2011
Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes. Journal of cutaneous pathology, 2012, Volume: 39, Issue:7 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Fibrin; Gemcitabine; Humans; Leukocytes; Male; Middle Aged; Skin; Thrombotic Microangiopathies	2012